Evaluation of anti-adipogenic active homoisoflavonoids from Portulaca oleracea

Zeitschrift fur Naturforschung - Section C Journal of Biosciences - Tập 74 Số 9-10 - Trang 265-273 - 2019
Jung Im Lee1, Jung Hwan Oh2, Chang‐Suk Kong2,1, Youngwan Seo3,4
1Marine Biotechnology Center for Pharmaceuticals and Foods, College of Medical and Life Sciences, Silla University , Busan 46958 , Republic of Korea
2Department of Food and Nutrition, College of Medical and Life Sciences , Silla University , Busan 46958 , Republic of Korea
3Department of Convergence Study on the Ocean Science and Technology, Ocean Science and Technology School, Korea Maritime and Ocean University, Busan 49112, Republic of Korea
4Division of Marine Bioscience, College of Ocean Science and Technology , Korea Maritime and Ocean University , Busan 49112 , Republic of Korea , Phone: +82-51-410-4328, Fax: +82-51-404-3538

Tóm tắt

Abstract This study was performed to isolate antiobesity components from the crude extract of Portulaca oleracea. The crude extract was partitioned into n-hexane, 85% aqueous methanol, n-butanol, and water fractions. Their effects on adipogenic differentiation were evaluated in 3T3-L1 cells. Among the solvent fractions from P. olearacea, the 85% aq. MeOH effectively reduced the levels of lipid accumulation. Further purification of 85% aq. MeOH led to the isolation of the known homoisoflavonoids 1–4, as the active substances. The administration of homoisoflavonoids to adipocyte cells decreased the lipid accumulation and glucose consumption and increased the release of glycerol into culture medium. In particular, homoisoflavonoid 3 effectively down-regulated the adipogenic transcription genes such as peroxisome proliferator activated receptor-γ (PPARγ) and CCAAT/enhancer-binding proteins (C/EBPα), and adipogenic target genes such as fatty acid binding protein 4 (FABP4), fatty acid transport protein 1 (FATP1), and acyl-CoA synthase 1 (ACS1).

Từ khóa


Tài liệu tham khảo

World Health Organization (WHO). Obesity and overweight 2017. http://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight.

Organization for Economic Co-operation and Development (OECD). OECD Obesity Update 2017. http://www.oecd.org/health/obesity-update.htm.

Kopelman PG. Obesity as a medical problem. Nature 2000;404:635–43.

Scott Lois K, Kumar S. Obesity and diabetes. Endocrinol Nutr 2009;56:S38–42.

Scott KM, Magnus A, McGee J, Elisabeth W, Mark A, Oakley B. Obesity and mental disorders in the adult general population. J Psychosom Res 2008;64:97–105.

Dobbs R, Sawers C, Thompson F, Manyika J, Woetzel JR, Child P, et al. Overcoming obesity: an initial economic analysis. Jakarta, Indonesia: McKinsey Global Institute, 2014.

Shimomura I, Robert EH, James AR, Shinji I, Yuriy B, Joseph L, et al. Insulin resistance and diabetes mellitus in transgenic mice expressing nuclear SREBP-1c in adipose tissue: model for congenital generalized lipodystrophy. Genes Dev 1998;12:3182–94.

Cara BE, Dorota BP, David SL. Childhood obesity: public-health crisis, common sense cure. Lancet 2002;360:473–82.

Yang ZJ, Liu CJ, Xiang L, Zheng YN. Phenolic alkaloids as a new class of antioxidants in Portulaca oleracea. Phytother Res 2009;23:1032–5.

Uddin MK, Juraimi AS, Hossain MS, Nahar MA, Ali ME, Rahman MM. Purslane weed (Portulaca oleracea): a prospective plant source of nutrition, omega-3 fatty acid, and antioxidant attributes. ScientificWorldJ 2014;951019.

Liu L, Howe P, Zhou YF, Xu ZQ, Hocart C, Zhan R. Fatty acids and beta-carotene in Australian purslane (Portulaca oleracea) varieties. J Chromatogr 2000;893:207–13.

Lee MS, Kim CT, Kim CJ, Cho YJ, Kim Y. Effects of Portulaca oleracea L. extract on lipolysis and hormone sensitive lipase (HSL) gene expression in 3T3-L1 adipocytes. Korean J Nutr 2006;39:742–7.

Lim YY, Quah EP. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chem 2007;103:734–40.

Xin HL, Xu YF, Hou YH, Zhang YN, Yue XQ, Lu JC, et al. Two novel triterpenoids from Portulaca oleracea L. Helv Chim Acta 2008;91:2075–80.

Xin HL, Hou YH, Xu YF, Yue XQ, Li M, Lu JC, et al. Portulacerebroside A: new Cerebroside from Portulaca oleracea L. Chin J Nat Med 2008;6:401–3.

Zhu HB, Wang YZ, Liu YX, Xia YL, Tang T. Analysis of flavonoids in Portulaca oleracea L. by UV-vis spectrophotometry with comparative study on different extraction technologies. Food Anal Methods 2010;3:90–7.

Iranshahy M, Javadi B, Iranshahi M, Jahanbakhsh SP, Mahyari S, Hassani FV, et al. A review of traditional uses, phytochemistry and pharmacology of Portulaca oleracea L. J Ethnopharmacol 2017;205:158–72.

Hosseini SZ, Alipour B, Ansarin K, Sharifi A. The Effect of Portulaca oleracea seeds on anthropometric measurements in asthmatic patients with overweight and obesity. J Food Nutr Sci 2015;3:103–7.

Hansen MB, Nielsen SE, Berg K. Re-examination and further development of a precise and rapid dye method for measuring cell growth/cell kill. J Immunol Methods 1989;119:203–10.

Kim H, Kong C-S, Lee JI, Kim H, Bae S, Seo Y. Evaluation of inhibitory effect of phlorotannins from Ecklonia cava on triglyceride accumulation in adipocyte. J Agric Food Chem 2013;61:8541–7.

Kong C-S, Lee JI, Kim YA, Kim J-A, Bak SS, Hong JW, et al. Evaluation on anti-adipogenic activity of flavonoid glucopyranosides from Salicornia herbacea. Proc Biochem 2012;47:1073–8.

Damodar K, Lee JT, Kim J-K, Jun J-G. Synthesis and in vitro evaluation of homoisoflavonoids as potent inhibitors of nitric oxide production in RAW-264.7 cells. Bioorg Med Chem Let 2018;28:2098–102.

Yan J, Sun LR, Zhou ZY, Chen YC, Zhang WM, Dai HF, et al. Homoisoflavonoids from the medicinal plant Portulaca oleracea. Phytochemistry 2012;80:37–41.

Alessi MC, Lijnen HR, Bastelica D, Juhan-Vague I. Adipose tissue and atherothrombosis. Pathophysiol Haemost Thromb 2004;33:290–7.

Rosen ED. The transcriptional basis of adipocyte development. Prostaglandins Leukot Essent Fatty Acids 2005;73:31–4.

Salas V, Noe V, Ciudad CJ, Romero MM, Remesar X, Esteve M. Short-term oleoyl-estrone treatment affects capacity to manage lipids in rat adipose tissue. BMC Genom 2007;8:292–7.

Chmurzyńska A. The multigene family of fatty acid-binding proteins (FABPs): function, structure and polymorphism. J Appl Genet 2006;47:39–48.

Coleman RA, Lewin TM, Van HC, Gonzalez-Baro MR. Do long-chain acyl-Coa synthetases regulate fatty acid entry into synthetic versus degradative pathways? J Nutr 2002;132:2123–6.

Lin L-G, Liu Q-Y, Ye Y. Naturally occurring homoisoflavonoids and their pharmacological activities. Planta Med 2014;80:1053–66.

Amschler G, Frahm AW, Hatzelmann A, Kilian U, Müller-Doblies D, Müller-Doblies U. Constituents from Veltheimia viridifolia; I. Homoisoflavones of the bulbs. Planta Med 1996;62:534–9.

Liang CH, Chan LP, Chou TH, Chiang FY, Yen CM, Chen PJ, et al. Brazilein from Caesalpinia sappan L. antioxidant inhibits adipocyte differentiation and induces apoptosis through caspase-3 activity and anthelmintic activities against Hymenolepis nana and Anisakis simplex. Evid Based Complement Alternat Med 2013;2013:864892.

Thông tin
Thông tin xuất bản

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Tập 74 Số 9-10

265-273

Thông tin tác giả